May 20, 2022

COVID impact, business opportunities, trends and forecasts – Queen Anne and Mangolia News

Evolve business intelligence, today released a new market research report on the global antibiotics market. According to the published study, “Global Antibiotics Market Size was valued at USD 39.87 Million in 2020 and is projected to reach USD 62.0 Billion by 2028, growing at a CAGR of 5.32% from 2021 to 2028.”

For more information on the report: https://report.evolvebi.com/index.php/sample/request?referer=parity&reportCode=010462

The COVID-19 pandemic has led to supply chain disruption leading to lower demand or supply shortages in the antibiotics market. Travel restrictions and social distancing measures have led to a sharp drop in consumer and business spending and this trend is expected to continue for some time. The trend and preferences of end users have changed due to the pandemic and led manufacturers, developers and service providers to adopt various strategies to stabilize the business.

In terms of the impact of COVID 19, the Antibiotics market report also includes the following data points:

  • COVID19 Impact on Antibiotics Market Size
  • End user/industry/application trend and preferences
  • Government policies/regulatory framework
  • Strategy of key actors to fight against negative impacts / post-COVID strategies
  • Opportunity in the Antibiotics Market

Analyst View

According to Nisha, Principal Analyst, Evolve Business Intelligence, “The recent COVID scenario is expected to have a positive impact on the antibiotics market. The pandemic has increased the number of covid patients in hospitals. The fear of COVID has increased the number of patients going to the hospital for several trivial symptoms, which has led to an increase in the use of antibiotics for several bacterial infections.

Competitive scenario
Some of the major antibiotic players with high market share include Abbott Laboratories, Allergan Plc, Hoffmann-La Roche Ltd., GlaxoSmithKline Plc. These players are using new products and development as the key strategy to gain significant market share to compete with the market leaders.

Segmental analysis
The antibiotics market is analyzed on the different segments mentioned below:

  • Classroom
    • Beta-lactam and beta-lactamase inhibitors
    • quinolone
    • Macrolide
    • Others
  • Origin of the drug
    • Natural
    • Semi-synthetic
    • Synthetic
  • Activity spectrum
    • Broad-spectrum antibiotic
    • Narrow-spectrum antibiotic

Report cover
The study also contains a complete value chain, along with details of the key factors affecting market growth (drivers, restraints, and opportunities). Additionally, the report includes 10 key players in the Antibiotics market ecosystem that have been strategically profiled along with the ranking/market share of key players. In the Company Profile section, the company’s core competencies have been thoroughly analyzed along with the competitive landscape of market players and strategies such as partnerships and collaboration, acquisitions, launches and product developments, contracts and business expansion adopted by them. to grow in the market.

The key players profiled in the report are:

  • Abbott Laboratories
  • Allergan AG
  • Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Merck & Co. Inc.
  • Mylan AG
  • Novartis International SA
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi

To request a free sample report: https://report.evolvebi.com/index.php/sample/request?referer=parity&reportCode=010462

Research Methodology
This research study makes substantial use of secondary sources, archival records, and databases (such as annual reports, press releases, magazines, trade maps, company websites, and other databases). paid data) to classify and gather useful information for this analysis. The whole process involves a review of the financial records of key industry participants. After determining the overall market size, the total market was divided into several segments and sub-segments, and this information was further verified by key industry specialists such as CEOs, Directors, VPs. presidents and marketing managers.

Report objectives

  • To define, describe and forecast the Antibiotics market, in terms of value, segmented on the basis of indication, type, technology and geography
  • Forecast market size in 4 key regions: Asia-Pacific (APAC), North America, Europe and Rest of the World (RoW)
  • To provide in-depth insights into the Antibiotics Market drivers, restraints, and opportunities
  • Provide an overview of value chain analysis relating to the Antibiotics industry
  • To strategically analyze each segment and sub-segment with respect to individual global growth trends and their contribution to the overall Antibiotics market
  • Analyze market opportunities by identifying high growth segments of the antibiotics market
  • To profile key players in the Antibiotics market and thoroughly analyze their core competencies
  • To analyze competitive developments such as partnerships, product launches and developments, contracts, and mergers and acquisitions carried out in the global Antibiotics market

About EvolveBI

Evolve Business Intelligence is a market research, business intelligence and consulting company that provides innovative solutions to tough business problems. Our market research reports include data useful for micro, small, medium and large businesses. We provide solutions ranging from simple data collection to business consulting.

Evolve Business Intelligence is built on the foundation of technological advancements providing highly accurate data through our in-house AI modeled data analysis and forecasting tool – EvolveBI. This tool tracks real-time data, including quarterly performance, annual performance, and recent developments for Fortune 2000 global companies.

Address

Evolve business intelligence
C-218, 2nd floor, M-Cube
NH 48, Balitha, Vapi
Gujarat 396191
India

Contact: +1 773 644 5507 / +91 635 396 3987
Email: [email protected]
Website: https://evolvebi.com/